A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy

NCT06983158 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
SUSPENDED
Status
12
Enrollment
INDUSTRY
Sponsor class

Stopped Per protocol stopping rule was met. Comprehensive review is needed prior to resuming enrollment.

Conditions

Interventions

Sponsor

Capsida Biotherapeutics, Inc.